TLOG Insider Trading Activity and SEC Form 4 Filings
TLOG insider trading summary
No open-market insider purchases or sales of Tetralogic Pharmaceuticals Corp (TLOG) have been reported on SEC Form 4 in the past 12 months.
Latest TLOG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 9, 2016 | Michael Steinmetz | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Kurt Wheeler | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Dennis Henner | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Nicholas Galakatos | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Clarus Ventures II GP, L.P. | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Clarus Ventures II, LLC | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Robert Liptak | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Nicholas Simon | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 9, 2016 | Clarus Lifesciences II, L.P. | 10% Owner | Sell | $37K (230,507 @ $0.16) |
| Feb 8, 2016 | Michael Steinmetz | 10% Owner | Sell | $20K (103,123 @ $0.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.